Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,679,628
+$3,451,630 QoQ
Shares Held
217,000
-45.8% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#118
of 494 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Dec 31, 2023CallValue
$33,689
CallShares
3,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Atika Capital Management LLC holds $138,478,275 across 17 Biotechnology names. ROIV ranks #8 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
88,000 | $16,480,639 | |
| 2 | ASND |
Ascendis Pharma A/S
|
61,000 | $16,269,919 | |
| 3 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
165,000 | $16,084,198 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
63,000 | $15,420,508 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
104,000 | $11,925,678 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
272,000 | $10,526,399 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
100,000 | $9,516,998 | |
| 8 | ROIV |
Roivant Sciences Ltd.
This page
|
217,000 | $7,679,628 |
All Filings in ROIV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,679,628 | 217,000 | Shares | Defined | 2026-08-13 | |
| 2024-06-30 | $4,227,998 | 400,000 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,638,688 | 534,980 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $33,689 | 3,000 | Call | Defined | 2024-02-13 | |
| 2023-12-31 | $8,309,973 | 739,980 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,365,599 | 545,000 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,016,879 | 398,500 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,579,298 | 485,000 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,474,398 | 560,000 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||